Kiora Pharmaceuticals Inc
KPRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001372514
No open-market purchases or sales by Kiora Pharmaceuticals Inc insiders were filed in the last 90 days; 22 institutions reported holding it in 13F filings for Q2 2026, worth $2.91M in total; no superinvestor holds it.
Other share classesKPHMW
Q2 2024 vs. Q1 2024
How the institutions holding Kiora Pharmaceuticals Inc changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 24 | 17 | −7 |
| SharesConverted for a 1-for-9 split | 1.24M | 1.42M | +183.2K (+14.8%) |
| Value | $7.87M | $5.97M | −$1.90M (−24.1%) |
New holders (4)
Institutions that held Kiora Pharmaceuticals Inc at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Stonepine Capital Management, LLC | 200,000 | $840.0K | 0.77% |
| UBS Group AG | 8,320 | $34.9K | 0.00% |
| Bank of America Corp | 20 | $84 | 0.00% |
| Activest Wealth Management | 3 | $13 | 0.00% |
Sold out (11)
Institutions that held Kiora Pharmaceuticals Inc at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Captrust Financial Advisors | 80,000 | $56.5K |
| XTX Topco Ltd | 24,909 | $17.6K |
| Vanguard Group Inc | 24,566 | $17.3K |
| HRT Financial LP | 22,864 | $16.0K |
| Renaissance Technologies LLC | 16,655 | $12.0K |
| Two Sigma Investments, LP | 10,351 | $7.31K |
| Virtu Financial LLC | 10,207 | $7.00K |
| Tower Research Capital LLC (TRC) | 4,187 | $2.96K |
| Wells Fargo & Company | 60 | $42 |
| FMR LLC | 7 | $5 |
| Albion Financial Group | 6 | $5 |